Glyburide Tablet
Product Images NDC 71335-2771

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 71335-2771). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glyburide-fig-1 (Glyburide Fig 1)

Chemical structure diagram of Glyburide, showing its molecular connectivity including aromatic rings, chlorine, methoxy, sulfonyl, amide, and cyclohexyl groups as part of the compound's chemical formula.*

FDA Label Image

Label (Lbl713352771)

Label for Glyburide Tablets USP 5 mg oral tablets, repackaged by Bryant Ranch Prepack, Inc. The label indicates 30 tablets per package, with storage instructions at 20° to 25°C and caution to keep the container tightly closed and protected from light. Manufactured by Cadila Pharmaceuticals Limited. The label includes the NDC 71335-2771-1 and QR codes for the package insert and product information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.